Search research articles
Contact Us
Filters
Showing results (111-120 of 126) with videos related to
Page
of 13
Sort By:
Clinical and Translational Science
|
January 12, 2016
Impact of GGCX, STX1B and FPGS Polymorphisms on Warfarin Dose Requirements in European-Americans and Egyptians
I S Hamadeh, M H Shahin, S M Lima, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
October 30, 1998
The unanticipated difficult airway with recommendations for management
E T Crosby, R M Cooper, M J Douglas, et al.
Clinical Pharmacology and Therapeutics
|
July 3, 2009
Hydrochlorothiazide and atenolol combination antihypertensive therapy: effects of drug initiation order
J A Johnson, Y Gong, K R Bailey, et al.
Clinical and Translational Science
|
March 8, 2016
Melatonin Pathway and Atenolol-Related Glucose Dysregulation: Is There a Correlation?
S W Chang, Y Gong, C W McDonough, et al.
The Pharmacogenomics Journal
|
February 22, 2012
Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression
J D Duarte, S T Turner, B Tran, et al.
Clinical Pharmacology and Therapeutics
|
March 19, 2014
Impact of CYP2D6 polymorphisms on clinical efficacy and tolerability of metoprolol tartrate
I S Hamadeh, T Y Langaee, R Dwivedi, et al.
The Pharmacogenomics Journal
|
September 28, 2016
Genome-wide association study identifies pharmacogenomic loci linked with specific antihypertensive drug treatment and new-onset diabetes
S-W Chang, C W McDonough, Y Gong, et al.
Anaesthesia
|
November 9, 2020
Project for Universal Management of Airways - part 1: concept and methods
N Chrimes, A Higgs, J A Law, et al.
Clinical Pharmacology and Therapeutics
|
May 24, 2012
The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy
R A Wilke, L B Ramsey, S G Johnson, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 20, 2016
Pharmacometabolomic Assessments of Atenolol and Hydrochlorothiazide Treatment Reveal Novel Drug Response Phenotypes
D M Rotroff, M H Shahin, S B Gurley, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 126) with videos related to
Sort By:
Page
of 13
Clinical and Translational Science
|
January 12, 2016
Impact of GGCX, STX1B and FPGS Polymorphisms on Warfarin Dose Requirements in European-Americans and Egyptians
I S Hamadeh, M H Shahin, S M Lima, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
October 30, 1998
The unanticipated difficult airway with recommendations for management
E T Crosby, R M Cooper, M J Douglas, et al.
Clinical Pharmacology and Therapeutics
|
July 3, 2009
Hydrochlorothiazide and atenolol combination antihypertensive therapy: effects of drug initiation order
J A Johnson, Y Gong, K R Bailey, et al.
Clinical and Translational Science
|
March 8, 2016
Melatonin Pathway and Atenolol-Related Glucose Dysregulation: Is There a Correlation?
S W Chang, Y Gong, C W McDonough, et al.
The Pharmacogenomics Journal
|
February 22, 2012
Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression
J D Duarte, S T Turner, B Tran, et al.
Clinical Pharmacology and Therapeutics
|
March 19, 2014
Impact of CYP2D6 polymorphisms on clinical efficacy and tolerability of metoprolol tartrate
I S Hamadeh, T Y Langaee, R Dwivedi, et al.
The Pharmacogenomics Journal
|
September 28, 2016
Genome-wide association study identifies pharmacogenomic loci linked with specific antihypertensive drug treatment and new-onset diabetes
S-W Chang, C W McDonough, Y Gong, et al.
Anaesthesia
|
November 9, 2020
Project for Universal Management of Airways - part 1: concept and methods
N Chrimes, A Higgs, J A Law, et al.
Clinical Pharmacology and Therapeutics
|
May 24, 2012
The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy
R A Wilke, L B Ramsey, S G Johnson, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 20, 2016
Pharmacometabolomic Assessments of Atenolol and Hydrochlorothiazide Treatment Reveal Novel Drug Response Phenotypes
D M Rotroff, M H Shahin, S B Gurley, et al.
Page
of 13